Belgrade University School of Medicine, Belgrade, Serbia.
Eur Arch Otorhinolaryngol. 2013 Mar;270(4):1405-10. doi: 10.1007/s00405-013-2383-6. Epub 2013 Feb 14.
Laryngeal precursor lesions represent areas of altered epithelium with an increased likelihood for progression to squamous cell carcinoma. The exact molecular mechanisms of malignant transformation of laryngeal mucosa are not completely clear, but are certainly due to deregulation of cell proliferation. To assess the potential value of the p16 and Ki-67 as markers of malignant progression, we undertook a retrospective immunohistochemical and morphometric analysis on biopsy specimens from patients with precancerous lesions in the larynx. Morphometric analysis of samples stained with p16 antibody showed epithelial cell positivity in 29 (100 %) of samples with simple hyperplasia, 31 (100 %) samples with basal/parabasal cell hyperplasia, 23 (88 %) samples with atypical hyperplasia and 20 (95 %) samples with in situ carcinoma. There was a significant difference in percentage of p16-positive cells between samples with simple hyperplasia and samples with in situ carcinoma. Morphometric analysis of samples stained with Ki-67 antibody showed epithelial cell positivity in 27 (93 %) of samples with simple hyperplasia, 30 (97 %) samples with basal/parabasal cell hyperplasia, 26 (100 %) samples with atypical hyperplasia and 18 (86 %) samples with in situ carcinoma. There was a significant difference not only in the percentage of Ki-67-positive cells between samples with simple hyperplasia and samples with in situ carcinoma, but also between samples with simple and basal/parabasal cell hyperplasia. Laryngeal epithelial precursor lesions show significantly opposite patterns in p16 and Ki-67 immunopositivity. Simple hyperplasia on average shows 12 % of Ki-67-positive cells and 46 % of p16-positive cells. In situ carcinoma on average shows 23 % of Ki-67-positive cells and 36 % of p16-positive cells.
喉前体病变代表上皮细胞发生改变的区域,其进展为鳞状细胞癌的可能性增加。喉黏膜恶性转化的确切分子机制尚不完全清楚,但肯定是由于细胞增殖失调所致。为了评估 p16 和 Ki-67 作为恶性进展标志物的潜在价值,我们对喉癌前病变患者的活检标本进行了回顾性免疫组织化学和形态计量学分析。用 p16 抗体染色的样本的形态计量学分析显示,单纯性增生的 29 例(100%)、基底/副基底细胞增生的 31 例(100%)、非典型增生的 23 例(88%)和原位癌的 20 例(95%)样本中上皮细胞呈阳性。单纯性增生样本和原位癌样本之间 p16 阳性细胞的百分比有显著差异。用 Ki-67 抗体染色的样本的形态计量学分析显示,单纯性增生的 27 例(93%)、基底/副基底细胞增生的 30 例(97%)、非典型增生的 26 例(100%)和原位癌的 18 例(86%)样本中上皮细胞呈阳性。不仅在单纯性增生和原位癌样本之间,而且在单纯性增生和基底/副基底细胞增生样本之间,Ki-67 阳性细胞的百分比都有显著差异。喉上皮前体病变的 p16 和 Ki-67 免疫阳性表现出明显相反的模式。单纯性增生平均有 12%的 Ki-67 阳性细胞和 46%的 p16 阳性细胞。原位癌平均有 23%的 Ki-67 阳性细胞和 36%的 p16 阳性细胞。